Trial NCT02759315

View at ClinicalTrials.gov 
Org. Study IDs: 3682-035
Secondary IDs: MK-3682-035

Last trial update was posted on 2019-06-26

MeSH Interventions

Ruzasvir Uprifosbuvir

MeSH Conditions

Hepatitis Hepatitis A Hepatitis C Hepatitis C, Chronic

Other Conditions


Stopping Reasons

The study was terminated based on review of Phase 2 efficacy data

Limitations And Caveats

N/A

Result Publications


Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID